Cointime

  • 快讯
  • 头条
  • 行情
  • 专栏
  • 活动
  • 比特币 ¥460,661.34 +0.61%
  • 以太坊 ¥13,470.74 +1.39%
  • 币安币 ¥4,085.49 +1.11%
  • Optimism ¥0.66 +1.24%
  • Arbitrum ¥0.59 +0.31%
  • Solana ¥536.39 +1.21%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥9.95 +0.92%
  • Avalanche ¥48.47 +8.17%
  • 比特币 ¥460,661.34 +0.61%
  • 以太坊 ¥13,470.74 +1.39%
  • 币安币 ¥4,085.49 +1.11%
  • Optimism ¥0.66 +1.24%
  • Arbitrum ¥0.59 +0.31%
  • Solana ¥536.39 +1.21%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥9.95 +0.92%
  • Avalanche ¥48.47 +8.17%
Home / Arcus Biosciences / investors

Arcus Biosciences

company

Investors

Number of Lead Investors
Number of Investors
3
18
Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.
Investor Name Lead Investor Funding Round
Gilead Sciences Yes Post-IPO Equity
GV Yes Series C
Aisling Capital - Series C
Biotechnology Value Fund - Series C
Celgene - Series C
Decheng Capital - Series C
Droia Ventures - Series C
EcoR1 Capital - Series C
Foresite Capital - Series C
Hillhouse Capital Group - Series C
Invus - Series C
Leerink Partners - Series C
Taiho Ventures - Series C
The Column Group - Series C
Wellington Management - Series C
Novartis - Series B
RTA Capital - Series B
Stanford University - Series B

Contact

Hayward,California,United States
+1 510-694-6200
Cointime
头条
  • 即时新闻
  • 全球政策
  • 比特币
  • 以太坊
  • 狗狗币
  • 区块链
  • 元宇宙
  • 区块链游戏
  • Web3
  • DeFi
  • NFT
热点
  • 项目报道
  • 行业洞见
  • 新闻
  • 教程
  • 政策解读
  • 专题
  • 专栏
  • 行情
  • 活动
  • 标签
RSS
  • 即时新闻
  • 头条
公司
  • 关于我们
  • 广告合作
  • 免责声明
  • © 2023 Cointime. 版权所有
  • 隐私政策
  • 服务条款